Teresita Bellido
Concepts (466)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteocytes | 60 | 2022 | 209 | 13.820 |
Why?
| Bone and Bones | 40 | 2021 | 519 | 7.800 |
Why?
| Osteoblasts | 53 | 2022 | 534 | 5.880 |
Why?
| Bone Resorption | 26 | 2022 | 319 | 5.100 |
Why?
| Osteogenesis | 30 | 2022 | 379 | 5.020 |
Why?
| Signal Transduction | 39 | 2022 | 1850 | 4.480 |
Why?
| Parathyroid Hormone | 14 | 2022 | 220 | 4.300 |
Why?
| Bone Remodeling | 20 | 2021 | 180 | 4.300 |
Why?
| Osteoclasts | 32 | 2021 | 461 | 4.040 |
Why?
| Apoptosis | 35 | 2017 | 1356 | 3.610 |
Why?
| Glucocorticoids | 12 | 2019 | 285 | 3.290 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 9 | 2022 | 32 | 3.260 |
Why?
| Connexin 43 | 14 | 2017 | 25 | 2.430 |
Why?
| Receptors, Notch | 5 | 2022 | 34 | 2.430 |
Why?
| Mice | 83 | 2022 | 6403 | 2.330 |
Why?
| Animals | 111 | 2022 | 14806 | 2.320 |
Why?
| Diphosphonates | 9 | 2012 | 97 | 2.310 |
Why?
| Bone Morphogenetic Proteins | 10 | 2020 | 66 | 2.290 |
Why?
| RANK Ligand | 10 | 2018 | 189 | 2.200 |
Why?
| Glycoproteins | 15 | 2019 | 137 | 2.150 |
Why?
| Mechanotransduction, Cellular | 10 | 2016 | 30 | 2.110 |
Why?
| Wnt Signaling Pathway | 10 | 2022 | 87 | 2.080 |
Why?
| Antioxidants | 4 | 2020 | 306 | 1.740 |
Why?
| beta Catenin | 8 | 2022 | 98 | 1.710 |
Why?
| Adaptor Proteins, Signal Transducing | 19 | 2020 | 215 | 1.600 |
Why?
| Osteoporosis | 9 | 2016 | 184 | 1.480 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 10 | 2013 | 110 | 1.450 |
Why?
| Intercellular Signaling Peptides and Proteins | 16 | 2019 | 128 | 1.310 |
Why?
| NF-E2-Related Factor 2 | 2 | 2017 | 62 | 1.210 |
Why?
| Focal Adhesion Kinase 2 | 3 | 2019 | 16 | 1.200 |
Why?
| Cells, Cultured | 30 | 2018 | 1840 | 1.190 |
Why?
| Mice, Inbred C57BL | 21 | 2022 | 2064 | 1.180 |
Why?
| Mice, Knockout | 17 | 2019 | 1006 | 1.160 |
Why?
| Anoikis | 2 | 2019 | 8 | 1.100 |
Why?
| Bone Density | 18 | 2019 | 436 | 1.070 |
Why?
| Receptors, Parathyroid Hormone | 3 | 2014 | 26 | 1.020 |
Why?
| Aging | 6 | 2018 | 776 | 0.860 |
Why?
| Mice, Transgenic | 11 | 2015 | 729 | 0.860 |
Why?
| Cell Differentiation | 11 | 2021 | 758 | 0.860 |
Why?
| Bone Marrow | 6 | 2016 | 412 | 0.820 |
Why?
| Calcitriol | 10 | 2005 | 49 | 0.810 |
Why?
| Weight-Bearing | 6 | 2016 | 66 | 0.800 |
Why?
| Cell Survival | 13 | 2019 | 695 | 0.800 |
Why?
| Alendronate | 8 | 2015 | 27 | 0.770 |
Why?
| Cell Communication | 3 | 2022 | 74 | 0.770 |
Why?
| Wnt Proteins | 7 | 2013 | 108 | 0.760 |
Why?
| Mitogen-Activated Protein Kinases | 5 | 2004 | 183 | 0.730 |
Why?
| Gap Junctions | 3 | 2017 | 29 | 0.720 |
Why?
| Stress, Mechanical | 5 | 2013 | 106 | 0.720 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2018 | 6 | 0.690 |
Why?
| Interleukin-6 | 10 | 1998 | 318 | 0.670 |
Why?
| Bone Density Conservation Agents | 6 | 2021 | 83 | 0.640 |
Why?
| Collagen Type I | 4 | 2015 | 95 | 0.640 |
Why?
| Bone Marrow Cells | 9 | 2021 | 245 | 0.630 |
Why?
| Adipogenesis | 1 | 2017 | 56 | 0.630 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2016 | 36 | 0.630 |
Why?
| ortho-Aminobenzoates | 1 | 2016 | 9 | 0.620 |
Why?
| Female | 37 | 2022 | 28983 | 0.620 |
Why?
| Fracture Healing | 1 | 2016 | 27 | 0.610 |
Why?
| Muscular Atrophy | 1 | 2017 | 76 | 0.610 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 100 | 0.610 |
Why?
| Fibroblast Growth Factors | 3 | 2017 | 60 | 0.610 |
Why?
| Down-Regulation | 7 | 2017 | 402 | 0.600 |
Why?
| Adipocytes | 1 | 2017 | 147 | 0.590 |
Why?
| Organ Size | 7 | 2019 | 263 | 0.590 |
Why?
| Cellular Microenvironment | 1 | 2016 | 28 | 0.590 |
Why?
| Fractures, Bone | 2 | 2016 | 124 | 0.590 |
Why?
| Humans | 59 | 2022 | 53032 | 0.580 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2016 | 137 | 0.570 |
Why?
| Caveolin 1 | 2 | 2013 | 22 | 0.570 |
Why?
| Peptides | 4 | 2015 | 284 | 0.570 |
Why?
| src-Family Kinases | 4 | 2005 | 60 | 0.560 |
Why?
| Periosteum | 2 | 2012 | 22 | 0.540 |
Why?
| Models, Biological | 10 | 2016 | 869 | 0.540 |
Why?
| MAP Kinase Signaling System | 4 | 2012 | 138 | 0.540 |
Why?
| Genetic Markers | 8 | 2020 | 124 | 0.530 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 122 | 0.510 |
Why?
| Gene Deletion | 7 | 2019 | 292 | 0.510 |
Why?
| Multiple Myeloma | 5 | 2022 | 2757 | 0.500 |
Why?
| Extracellular Matrix Proteins | 5 | 2018 | 80 | 0.500 |
Why?
| Hematopoietic Stem Cells | 2 | 2012 | 233 | 0.500 |
Why?
| Estrogens | 6 | 2007 | 257 | 0.490 |
Why?
| Muscles | 5 | 1993 | 103 | 0.470 |
Why?
| Phosphorylation | 12 | 2014 | 644 | 0.470 |
Why?
| Phosphates | 5 | 2016 | 49 | 0.470 |
Why?
| Cell Line | 16 | 2014 | 1226 | 0.460 |
Why?
| Hyperostosis | 2 | 2022 | 3 | 0.440 |
Why?
| RNA, Messenger | 8 | 2017 | 1276 | 0.440 |
Why?
| Up-Regulation | 7 | 2014 | 538 | 0.440 |
Why?
| Enzyme Inhibitors | 6 | 2014 | 471 | 0.430 |
Why?
| Phosphoproteins | 3 | 2018 | 121 | 0.420 |
Why?
| Enzyme Activation | 9 | 2010 | 345 | 0.400 |
Why?
| Gene Expression Regulation | 8 | 2017 | 1146 | 0.400 |
Why?
| Gene Expression | 5 | 2017 | 717 | 0.390 |
Why?
| Focal Adhesion Kinase 1 | 2 | 2007 | 15 | 0.380 |
Why?
| MicroRNAs | 3 | 2019 | 366 | 0.360 |
Why?
| Cytokines | 7 | 2014 | 704 | 0.350 |
Why?
| Cell Membrane | 2 | 2007 | 282 | 0.340 |
Why?
| Estrogen Receptor beta | 2 | 2007 | 59 | 0.330 |
Why?
| Estrogen Receptor alpha | 2 | 2007 | 110 | 0.320 |
Why?
| Receptors, Estrogen | 6 | 2006 | 152 | 0.320 |
Why?
| Monocytes | 1 | 2008 | 159 | 0.320 |
Why?
| X-Ray Microtomography | 5 | 2021 | 64 | 0.310 |
Why?
| Osteolysis | 3 | 2022 | 91 | 0.310 |
Why?
| Weightlessness | 1 | 2006 | 17 | 0.310 |
Why?
| Osteoprotegerin | 2 | 2016 | 52 | 0.310 |
Why?
| Membrane Glycoproteins | 5 | 2003 | 295 | 0.300 |
Why?
| Protein-Tyrosine Kinases | 3 | 2010 | 108 | 0.300 |
Why?
| Dexamethasone | 7 | 2017 | 397 | 0.300 |
Why?
| Calcifediol | 4 | 1991 | 10 | 0.290 |
Why?
| HeLa Cells | 10 | 2017 | 304 | 0.290 |
Why?
| Cell Nucleus | 5 | 2013 | 219 | 0.290 |
Why?
| Integrins | 1 | 2005 | 39 | 0.280 |
Why?
| Transcription Factors | 3 | 2004 | 640 | 0.280 |
Why?
| Caspases | 3 | 2006 | 154 | 0.280 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-5 | 3 | 2015 | 6 | 0.280 |
Why?
| Male | 22 | 2020 | 28343 | 0.280 |
Why?
| Skull | 5 | 2015 | 78 | 0.280 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 27 | 0.270 |
Why?
| Caspase 3 | 5 | 2017 | 140 | 0.260 |
Why?
| Estradiol | 9 | 2007 | 245 | 0.260 |
Why?
| Multienzyme Complexes | 1 | 2003 | 47 | 0.250 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 78 | 0.250 |
Why?
| Calcium Channels | 2 | 2001 | 61 | 0.250 |
Why?
| Antigens, CD | 4 | 2000 | 264 | 0.250 |
Why?
| Osteoporosis, Postmenopausal | 3 | 2014 | 36 | 0.240 |
Why?
| Actins | 2 | 2005 | 140 | 0.240 |
Why?
| Rats | 9 | 2014 | 3596 | 0.240 |
Why?
| Protein Kinases | 2 | 2014 | 95 | 0.240 |
Why?
| Kinetics | 8 | 2004 | 740 | 0.240 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 2016 | 443 | 0.230 |
Why?
| Phosphotyrosine | 2 | 1999 | 9 | 0.230 |
Why?
| Dihydrotestosterone | 4 | 2006 | 20 | 0.220 |
Why?
| Transfection | 6 | 2007 | 436 | 0.220 |
Why?
| Bone Matrix | 2 | 2019 | 22 | 0.220 |
Why?
| Transcription, Genetic | 8 | 2006 | 465 | 0.220 |
Why?
| Disease Models, Animal | 6 | 2021 | 1700 | 0.220 |
Why?
| Receptors, Androgen | 3 | 2006 | 54 | 0.210 |
Why?
| Cell Division | 6 | 2005 | 370 | 0.200 |
Why?
| Neoplasm Proteins | 1 | 2003 | 386 | 0.200 |
Why?
| Ovariectomy | 5 | 2014 | 136 | 0.200 |
Why?
| Trans-Activators | 3 | 2018 | 162 | 0.200 |
Why?
| Dentin | 1 | 2019 | 6 | 0.200 |
Why?
| Calcitonin | 1 | 1999 | 40 | 0.190 |
Why?
| Phenotype | 3 | 2020 | 842 | 0.190 |
Why?
| Lymphokines | 2 | 1997 | 24 | 0.190 |
Why?
| Phylogeny | 1 | 2020 | 269 | 0.190 |
Why?
| Growth Inhibitors | 2 | 1997 | 33 | 0.190 |
Why?
| DNA-Binding Proteins | 3 | 2003 | 512 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 4 | 2021 | 1572 | 0.190 |
Why?
| Cell Proliferation | 2 | 2016 | 1128 | 0.190 |
Why?
| Receptors, Interleukin-17 | 1 | 2018 | 3 | 0.180 |
Why?
| Dental Cementum | 1 | 2018 | 1 | 0.180 |
Why?
| Tooth Ankylosis | 1 | 2018 | 1 | 0.180 |
Why?
| Gonadal Steroid Hormones | 3 | 2007 | 46 | 0.180 |
Why?
| Anabolic Agents | 1 | 2019 | 35 | 0.180 |
Why?
| Protein Binding | 4 | 2011 | 787 | 0.180 |
Why?
| Tretinoin | 1 | 1999 | 64 | 0.180 |
Why?
| Bone Diseases | 2 | 2017 | 107 | 0.180 |
Why?
| Mefloquine | 1 | 2018 | 5 | 0.180 |
Why?
| Cyclins | 1 | 1998 | 57 | 0.180 |
Why?
| Primary Cell Culture | 2 | 2017 | 68 | 0.170 |
Why?
| Chick Embryo | 6 | 2001 | 75 | 0.170 |
Why?
| Absorptiometry, Photon | 2 | 2019 | 172 | 0.170 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 716 | 0.170 |
Why?
| Repressor Proteins | 1 | 2019 | 171 | 0.160 |
Why?
| Nuclear Respiratory Factor 1 | 1 | 2017 | 2 | 0.160 |
Why?
| Femur | 2 | 2015 | 144 | 0.160 |
Why?
| Bone Development | 1 | 2018 | 72 | 0.160 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 13 | 0.160 |
Why?
| Glucuronidase | 1 | 2017 | 50 | 0.160 |
Why?
| Osteoporotic Fractures | 1 | 2017 | 14 | 0.160 |
Why?
| Mice, 129 Strain | 1 | 2017 | 52 | 0.160 |
Why?
| Hyponatremia | 1 | 2017 | 15 | 0.160 |
Why?
| Mutation | 4 | 2018 | 1432 | 0.160 |
Why?
| Oxidative Stress | 2 | 2017 | 967 | 0.160 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 124 | 0.160 |
Why?
| Teriparatide | 2 | 2011 | 17 | 0.160 |
Why?
| Hypophosphatemia, Familial | 1 | 2016 | 1 | 0.150 |
Why?
| Cyclin D1 | 1 | 2016 | 62 | 0.150 |
Why?
| Receptors, Interleukin | 1 | 1996 | 12 | 0.150 |
Why?
| Receptors, Cytokine | 1 | 1996 | 12 | 0.150 |
Why?
| Receptors, Nerve Growth Factor | 1 | 1996 | 8 | 0.150 |
Why?
| Etoposide | 4 | 2005 | 89 | 0.150 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2010 | 20 | 0.150 |
Why?
| Random Allocation | 1 | 2017 | 326 | 0.150 |
Why?
| Immunohistochemistry | 3 | 2017 | 1143 | 0.150 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 84 | 0.150 |
Why?
| Diet | 1 | 2020 | 613 | 0.150 |
Why?
| Calcium | 4 | 2003 | 468 | 0.150 |
Why?
| Hindlimb | 1 | 2015 | 28 | 0.140 |
Why?
| Estrenes | 3 | 2006 | 16 | 0.140 |
Why?
| Protein Structure, Tertiary | 4 | 2015 | 303 | 0.140 |
Why?
| Core Binding Factor Alpha 1 Subunit | 2 | 2006 | 49 | 0.140 |
Why?
| Hindlimb Suspension | 1 | 2015 | 50 | 0.140 |
Why?
| Peptide Fragments | 3 | 2015 | 266 | 0.140 |
Why?
| Hematopoiesis | 2 | 2014 | 85 | 0.140 |
Why?
| Sex Characteristics | 1 | 2017 | 206 | 0.140 |
Why?
| Adiposity | 1 | 2016 | 144 | 0.140 |
Why?
| Mutation, Missense | 1 | 2015 | 117 | 0.140 |
Why?
| Osteocalcin | 3 | 2014 | 46 | 0.140 |
Why?
| Homeostasis | 2 | 2012 | 238 | 0.140 |
Why?
| Testosterone | 1 | 1995 | 126 | 0.140 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.140 |
Why?
| Receptors, Calcitriol | 3 | 2005 | 27 | 0.130 |
Why?
| Promoter Regions, Genetic | 3 | 2008 | 562 | 0.130 |
Why?
| Nucleic Acid Synthesis Inhibitors | 2 | 2005 | 17 | 0.130 |
Why?
| Sirtuin 1 | 1 | 2014 | 29 | 0.130 |
Why?
| Protein Kinase C | 2 | 2003 | 79 | 0.130 |
Why?
| Organ Culture Techniques | 1 | 2014 | 56 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 154 | 0.130 |
Why?
| Myeloproliferative Disorders | 1 | 2014 | 25 | 0.130 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2014 | 29 | 0.130 |
Why?
| Time Factors | 7 | 2015 | 3439 | 0.130 |
Why?
| Lymphoid Tissue | 1 | 1994 | 26 | 0.130 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2016 | 188 | 0.130 |
Why?
| LDL-Receptor Related Proteins | 2 | 2011 | 12 | 0.130 |
Why?
| Receptors, Steroid | 1 | 1993 | 26 | 0.130 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 68 | 0.130 |
Why?
| Transcriptome | 1 | 2016 | 344 | 0.130 |
Why?
| Injections, Subcutaneous | 1 | 2013 | 66 | 0.130 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2014 | 167 | 0.130 |
Why?
| Blotting, Western | 5 | 2011 | 721 | 0.120 |
Why?
| Receptor Cross-Talk | 1 | 2013 | 7 | 0.120 |
Why?
| TCF Transcription Factors | 1 | 2013 | 11 | 0.120 |
Why?
| Hematologic Neoplasms | 1 | 2014 | 89 | 0.120 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 132 | 0.120 |
Why?
| Flavonoids | 1 | 2013 | 69 | 0.120 |
Why?
| Ulna | 2 | 2013 | 16 | 0.120 |
Why?
| Protein Transport | 1 | 2013 | 207 | 0.110 |
Why?
| RNA, Small Interfering | 1 | 2013 | 269 | 0.110 |
Why?
| Arrestins | 1 | 2011 | 1 | 0.110 |
Why?
| Societies, Scientific | 1 | 2011 | 15 | 0.110 |
Why?
| Transgenes | 1 | 2011 | 64 | 0.110 |
Why?
| Absorption | 1 | 2011 | 23 | 0.110 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 173 | 0.110 |
Why?
| Minerals | 1 | 2011 | 32 | 0.110 |
Why?
| Health | 1 | 2011 | 29 | 0.110 |
Why?
| Ligands | 3 | 2007 | 256 | 0.110 |
Why?
| Flow Cytometry | 2 | 2012 | 583 | 0.110 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 181 | 0.110 |
Why?
| Etidronic Acid | 2 | 2001 | 6 | 0.110 |
Why?
| Lumbar Vertebrae | 2 | 2018 | 113 | 0.110 |
Why?
| Cytokine Receptor gp130 | 4 | 2000 | 14 | 0.110 |
Why?
| Culture Media, Conditioned | 2 | 2017 | 52 | 0.100 |
Why?
| Fibroblasts | 3 | 2001 | 380 | 0.100 |
Why?
| Muscle, Skeletal | 1 | 2017 | 832 | 0.100 |
Why?
| Estrogen Antagonists | 2 | 2007 | 23 | 0.100 |
Why?
| Extracellular Matrix | 1 | 2010 | 122 | 0.100 |
Why?
| Spine | 1 | 2010 | 125 | 0.090 |
Why?
| Hormones | 2 | 2008 | 66 | 0.090 |
Why?
| Dactinomycin | 2 | 2003 | 24 | 0.090 |
Why?
| Integrases | 1 | 2008 | 47 | 0.090 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 114 | 0.090 |
Why?
| Gene Silencing | 1 | 2008 | 131 | 0.090 |
Why?
| Nifedipine | 2 | 2001 | 24 | 0.090 |
Why?
| Biomedical Research | 1 | 2011 | 245 | 0.090 |
Why?
| Molecular Structure | 2 | 2006 | 334 | 0.090 |
Why?
| Stem Cells | 2 | 2006 | 194 | 0.080 |
Why?
| Phospholipids | 1 | 1987 | 61 | 0.080 |
Why?
| Base Sequence | 4 | 1998 | 755 | 0.080 |
Why?
| Dihydroxycholecalciferols | 1 | 1987 | 3 | 0.080 |
Why?
| Cattle | 1 | 2008 | 225 | 0.080 |
Why?
| Tibia | 1 | 2007 | 115 | 0.080 |
Why?
| bcl-Associated Death Protein | 2 | 2003 | 14 | 0.080 |
Why?
| Leukemia Inhibitory Factor | 2 | 1997 | 15 | 0.080 |
Why?
| Weight Gain | 1 | 2008 | 232 | 0.080 |
Why?
| Genotype | 1 | 2008 | 637 | 0.080 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 68 | 0.080 |
Why?
| Spleen | 1 | 2008 | 200 | 0.080 |
Why?
| Fatty Acids | 1 | 1987 | 178 | 0.080 |
Why?
| Membrane Proteins | 1 | 1989 | 390 | 0.080 |
Why?
| Disease Progression | 2 | 2021 | 900 | 0.080 |
Why?
| Cell Count | 1 | 2006 | 196 | 0.080 |
Why?
| RNA | 2 | 2005 | 182 | 0.080 |
Why?
| Caveolae | 1 | 2005 | 6 | 0.070 |
Why?
| Injections | 1 | 2005 | 66 | 0.070 |
Why?
| Physical Stimulation | 1 | 2005 | 35 | 0.070 |
Why?
| Kidney | 1 | 2011 | 834 | 0.070 |
Why?
| beta-Cyclodextrins | 1 | 2005 | 15 | 0.070 |
Why?
| Tubulin | 1 | 2005 | 22 | 0.070 |
Why?
| src Homology Domains | 2 | 2001 | 9 | 0.070 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 7 | 0.070 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 39 | 0.070 |
Why?
| Cytoskeleton | 1 | 2005 | 53 | 0.070 |
Why?
| Cycloheximide | 3 | 2005 | 33 | 0.070 |
Why?
| Cell Line, Tumor | 2 | 2021 | 1504 | 0.070 |
Why?
| Carrier Proteins | 2 | 2003 | 373 | 0.070 |
Why?
| Drug Synergism | 1 | 2004 | 171 | 0.070 |
Why?
| Receptors, Interleukin-6 | 3 | 2000 | 31 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2005 | 428 | 0.070 |
Why?
| Binding Sites | 3 | 2012 | 471 | 0.070 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 214 | 0.070 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 38 | 0.060 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 39 | 0.060 |
Why?
| Carcinogens | 1 | 2005 | 243 | 0.060 |
Why?
| CD40 Ligand | 1 | 2003 | 18 | 0.060 |
Why?
| Prednisolone | 2 | 2002 | 62 | 0.060 |
Why?
| Models, Genetic | 1 | 2003 | 204 | 0.060 |
Why?
| NF-kappa B | 2 | 2014 | 345 | 0.060 |
Why?
| DNA | 3 | 2005 | 583 | 0.060 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 134 | 0.060 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 157 | 0.060 |
Why?
| Tumor Cells, Cultured | 2 | 2002 | 521 | 0.060 |
Why?
| Embryo, Mammalian | 1 | 2001 | 72 | 0.060 |
Why?
| Luminescent Proteins | 1 | 2001 | 71 | 0.060 |
Why?
| Clodronic Acid | 1 | 2021 | 20 | 0.060 |
Why?
| Calcium Channel Blockers | 1 | 2001 | 70 | 0.050 |
Why?
| STAT3 Transcription Factor | 2 | 2000 | 84 | 0.050 |
Why?
| Models, Animal | 2 | 2013 | 267 | 0.050 |
Why?
| Isoquinolines | 1 | 2001 | 25 | 0.050 |
Why?
| Interleukin-5 | 1 | 2000 | 7 | 0.050 |
Why?
| Biotinylation | 1 | 2001 | 39 | 0.050 |
Why?
| Cell-Free System | 1 | 2000 | 15 | 0.050 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 213 | 0.050 |
Why?
| Body Weight | 2 | 2019 | 603 | 0.050 |
Why?
| Orchiectomy | 2 | 2002 | 45 | 0.050 |
Why?
| Fluorescent Dyes | 1 | 2001 | 122 | 0.050 |
Why?
| Odontogenesis | 1 | 2019 | 1 | 0.050 |
Why?
| Odontoblasts | 1 | 2019 | 5 | 0.050 |
Why?
| Dental Pulp | 1 | 2019 | 3 | 0.050 |
Why?
| In Situ Nick-End Labeling | 1 | 1999 | 69 | 0.050 |
Why?
| Recombinant Proteins | 2 | 1998 | 595 | 0.050 |
Why?
| Semaphorins | 1 | 2019 | 3 | 0.050 |
Why?
| Rifabutin | 1 | 1999 | 6 | 0.050 |
Why?
| Lactams, Macrocyclic | 1 | 1999 | 14 | 0.050 |
Why?
| Isotretinoin | 1 | 1999 | 13 | 0.050 |
Why?
| Quinones | 1 | 1999 | 12 | 0.050 |
Why?
| Benzoquinones | 1 | 1999 | 35 | 0.050 |
Why?
| Periodontal Ligament | 1 | 2018 | 2 | 0.050 |
Why?
| Tooth Eruption | 1 | 2018 | 2 | 0.050 |
Why?
| Transcription Factor AP-1 | 1 | 2019 | 71 | 0.050 |
Why?
| Sodium | 2 | 1991 | 89 | 0.050 |
Why?
| Mice, Mutant Strains | 2 | 2015 | 89 | 0.050 |
Why?
| Cell Adhesion Molecules | 1 | 1999 | 97 | 0.050 |
Why?
| Biological Transport | 2 | 1991 | 191 | 0.040 |
Why?
| Oligonucleotides, Antisense | 1 | 1998 | 32 | 0.040 |
Why?
| Interleukin-17 | 1 | 2018 | 40 | 0.040 |
Why?
| Cytoplasm | 3 | 2004 | 112 | 0.040 |
Why?
| Growth Substances | 1 | 1998 | 34 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 100 | 0.040 |
Why?
| Connective Tissue Cells | 1 | 1997 | 1 | 0.040 |
Why?
| Hyperparathyroidism, Primary | 1 | 2018 | 54 | 0.040 |
Why?
| Ciliary Neurotrophic Factor | 1 | 1997 | 11 | 0.040 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 41 | 0.040 |
Why?
| Osteogenesis Imperfecta | 1 | 2018 | 37 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 1995 | 1036 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1997 | 34 | 0.040 |
Why?
| Endometrial Neoplasms | 1 | 1999 | 155 | 0.040 |
Why?
| HMGB1 Protein | 1 | 2017 | 17 | 0.040 |
Why?
| Genetic Complementation Test | 1 | 2017 | 54 | 0.040 |
Why?
| Analysis of Variance | 1 | 1999 | 676 | 0.040 |
Why?
| Alkaline Phosphatase | 1 | 1997 | 101 | 0.040 |
Why?
| Proto-Oncogene Proteins | 3 | 2005 | 183 | 0.040 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 69 | 0.040 |
Why?
| Lymphocyte Activation | 2 | 1995 | 214 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 2 | 1994 | 52 | 0.040 |
Why?
| Tumor Suppressor Protein p53 | 1 | 1998 | 258 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2018 | 198 | 0.040 |
Why?
| Receptor, Ciliary Neurotrophic Factor | 1 | 1996 | 1 | 0.040 |
Why?
| Receptors, Interleukin-11 | 1 | 1996 | 1 | 0.040 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 1996 | 1 | 0.040 |
Why?
| Receptors, OSM-LIF | 1 | 1996 | 2 | 0.040 |
Why?
| Receptors, Oncostatin M | 1 | 1996 | 2 | 0.040 |
Why?
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1996 | 2 | 0.040 |
Why?
| Gait | 1 | 2017 | 91 | 0.040 |
Why?
| Gene Knock-In Techniques | 1 | 2015 | 31 | 0.040 |
Why?
| Biological Assay | 1 | 1996 | 59 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 216 | 0.040 |
Why?
| Amino Acid Substitution | 1 | 2015 | 111 | 0.040 |
Why?
| X-Rays | 1 | 2015 | 57 | 0.040 |
Why?
| Genetic Loci | 1 | 2015 | 64 | 0.040 |
Why?
| Accidental Falls | 1 | 2017 | 116 | 0.040 |
Why?
| Epigenetic Repression | 1 | 2014 | 1 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2015 | 213 | 0.030 |
Why?
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 2 | 0.030 |
Why?
| Lymphocytes | 1 | 1995 | 174 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2014 | 11 | 0.030 |
Why?
| Steroids | 1 | 1995 | 55 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 435 | 0.030 |
Why?
| Androgens | 2 | 2007 | 74 | 0.030 |
Why?
| Antigens, Differentiation | 1 | 2014 | 26 | 0.030 |
Why?
| Adjuvants, Immunologic | 1 | 1994 | 64 | 0.030 |
Why?
| Antibodies, Neutralizing | 1 | 2014 | 71 | 0.030 |
Why?
| Plasmids | 2 | 2004 | 182 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2014 | 148 | 0.030 |
Why?
| Bucladesine | 1 | 1993 | 5 | 0.030 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1993 | 10 | 0.030 |
Why?
| Diglycerides | 1 | 1993 | 14 | 0.030 |
Why?
| Staurosporine | 1 | 1993 | 17 | 0.030 |
Why?
| Alkaloids | 1 | 1993 | 36 | 0.030 |
Why?
| Body Composition | 1 | 2015 | 354 | 0.030 |
Why?
| Algorithms | 1 | 2017 | 738 | 0.030 |
Why?
| Haversian System | 1 | 2012 | 1 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 566 | 0.030 |
Why?
| Vanadates | 1 | 2012 | 13 | 0.030 |
Why?
| Transforming Growth Factor beta | 2 | 2006 | 169 | 0.030 |
Why?
| Binding, Competitive | 1 | 2012 | 134 | 0.030 |
Why?
| Heart | 1 | 1994 | 348 | 0.030 |
Why?
| Tissue Distribution | 1 | 2012 | 186 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2011 | 76 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 1993 | 554 | 0.030 |
Why?
| Ion Channels | 1 | 2012 | 73 | 0.030 |
Why?
| Spectrometry, X-Ray Emission | 1 | 2011 | 9 | 0.030 |
Why?
| Phosphorus Radioisotopes | 1 | 1991 | 18 | 0.030 |
Why?
| Risk Assessment | 1 | 2017 | 1418 | 0.030 |
Why?
| Rats, Long-Evans | 1 | 2011 | 25 | 0.030 |
Why?
| Cholecalciferol | 1 | 1991 | 19 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2011 | 119 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2011 | 94 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 215 | 0.030 |
Why?
| Rabbits | 1 | 2012 | 462 | 0.030 |
Why?
| Spectrum Analysis, Raman | 1 | 2011 | 72 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 2011 | 122 | 0.030 |
Why?
| Motor Activity | 1 | 2011 | 270 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 895 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2014 | 1810 | 0.020 |
Why?
| Physical Exertion | 1 | 2009 | 73 | 0.020 |
Why?
| Leucine | 1 | 1989 | 107 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1290 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2007 | 91 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2007 | 75 | 0.020 |
Why?
| Weightlessness Simulation | 1 | 2007 | 25 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 583 | 0.020 |
Why?
| Risk Factors | 1 | 2017 | 4007 | 0.020 |
Why?
| 24,25-Dihydroxyvitamin D 3 | 1 | 1987 | 3 | 0.020 |
Why?
| Smad Proteins | 1 | 2006 | 14 | 0.020 |
Why?
| Response Elements | 1 | 2006 | 37 | 0.020 |
Why?
| Vitamin D Deficiency | 1 | 1987 | 45 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2006 | 51 | 0.020 |
Why?
| Chickens | 1 | 1987 | 123 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 8 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 11 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 20 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 20 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 103 | 0.020 |
Why?
| Cholera Toxin | 1 | 2004 | 16 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2005 | 33 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 48 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 57 | 0.020 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 48 | 0.020 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2003 | 16 | 0.020 |
Why?
| Caspase Inhibitors | 1 | 2003 | 34 | 0.020 |
Why?
| Tensile Strength | 1 | 2003 | 34 | 0.020 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 5 | 0.020 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 6 | 0.020 |
Why?
| Phosphotransferases | 1 | 2003 | 24 | 0.020 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 68 | 0.020 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 30 | 0.020 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 85 | 0.020 |
Why?
| Genes, Reporter | 1 | 2003 | 116 | 0.020 |
Why?
| Compressive Strength | 1 | 2002 | 16 | 0.020 |
Why?
| Seminal Vesicles | 1 | 2002 | 18 | 0.020 |
Why?
| Uterus | 1 | 2002 | 111 | 0.010 |
Why?
| Pyrazoles | 1 | 2002 | 119 | 0.010 |
Why?
| Oncostatin M | 1 | 2000 | 5 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 58 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2001 | 146 | 0.010 |
Why?
| Sex Factors | 1 | 2001 | 817 | 0.010 |
Why?
| Stromal Cells | 1 | 1997 | 98 | 0.010 |
Why?
| Proto-Oncogene Proteins c-rel | 1 | 1995 | 5 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1995 | 33 | 0.010 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 12 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1274 | 0.010 |
Why?
| Myocardium | 1 | 1994 | 468 | 0.010 |
Why?
| Adult | 1 | 1995 | 14382 | 0.000 |
Why?
|
|
Bellido's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|